Inositol polyphosphate-1-phosphatase (INPP1) is an enzyme that is responsible for glycolysis and lipid metabolism. Here, we discovered that INPP1 expression was upregulated in CC tissues compared to that in adjacent normal tissues by RT-qPCR.
| INTRODUC TI ON
Cervical cancer (CC) is the third most common leading cause of cancer death among females in developing countries. 1 More than 274 000 individuals die each year. 2 In China, approximately 98 900 new cases were diagnosed in 2015, which accounted for 18.7% of the global incidence. 3 Additionally, 30% of patients were <44 years old. 4 Reportedly, the 5-year survival rates for locally advanced CC vary as follows: 58% for stage IIB, 35% for IIIA, 32% for IIIB and 16% for stage IVA. 5 Therefore, it is urgent to identify novel molecular markers to improve the early diagnosis rate of CC and to develop an effective treatment strategy.
Inositol polyphosphate-1-phosphatase (INPP1) is an enzyme that dephosphorylates free polyphosphorylated inositols, 6 key molecules involved in phosphatidylinositol signalling pathways. 7 Presently, it has been reported that INPP1 is up-regulated in human colorectal cancer. 8 Daniel et al 9 also found that INPP1 is highly expressed in aggressive melanoma, prostate, ovarian and breast cancer cells to promote migration and invasion; this finding suggests that INPP1 may function as an oncogene. However, the role of INPP1 in CC is still unclear.
MicroRNAs (miRNAs) are small non-coding RNAs that can bind to the 3′ UTR of target mRNAs, resulting in translational repression or degradation to regulate a wide range of physiological and pathological processes. [10] [11] [12] Recent findings demonstrate that miRNA also binds to the 3′ UTR of mRNAs to raise the expression levels of their target genes. [13] [14] [15] Furthermore, accumulating evidence has indicated that the miRNA profiles were differentially expressed in human cancerous tissues and adjacent normal tissues. 16, 17 The dysregulated miRNAs may function as tumour suppressors or oncogenes, 18 which present diagnostic and prognostic values in clinical applications. 19, 20 miR-27a was found to be up-regulated and to promote malignancy in non-small-cell lung cancer, breast cancer, prostate cancer, liver cancer, CC, etc. [21] [22] [23] [24] [25] In this report, we show that INPP1 is up-regulated in CC tissues compared with the levels in adjacent normal tissues. Inositol polyphosphate-1-phosphatase promoted cell proliferation and invasion/ migration. miR-27a bound to the 3′ UTR of INPP1 to increase the expression in CC cells. Rescue experiments indicated that INPP1 is a functional target gene of miR-27a. Overall, our present work proved that miR-27a promotes INPP1 expression to contribute to the malignant properties of CC cells, which may serve as biomarkers for the diagnosis of CC. C33A was cultured in DMEM. All cells were incubated in a humidified atmosphere at 37°C with 5% CO 2 .
| MATERIAL S AND ME THODS

| Human cervical cancer tissue specimens and cell lines
| Plasmid construction
The miR-27a precursor was cloned from the genome by PCR and was inserted into the pcDNA3 vector by BamHI/EcoRI digestion. Small 
| RNA extraction and real-time PCR
RNA from patient tissues was extracted by the miRcute miRNA Isolation Kit (Tiangen Biotech) according to the manufacturer's instructions. TRIzol reagent (Invitrogen) was used to isolate the total RNA from CC cells. Then, reverse transcriptase-polymerase chain reaction (RT-PCR) methods were used for cDNA synthesis with TA B L E 1 Sequences of the primers used in this study Name Sequence (5′-3′) snRNA was used as an internal control. The relative transcript-level fold-change was calculated using the 2 −∆∆Ct method. 26 
| Western blot analysis
The protein samples were obtained by using radioimmunoprecipita- 
| Luciferase reporter assays
| Cell viability assay and colony formation assay
HeLa (8 × 10 4 cells/well), SiHa (1 × 10 5 cells/well) and C33A
(1 × 10 5 cells/well) cells were inoculated into 24-well plates.
After 16-18 hours, 1 μg of the plasmids was transfected using Lipofectamine 2000 reagent (Invitrogen). After 24 hours of transfection, the cells were digested with 0.01% trypsin and counted by a haemocytometer. HeLa (2 × 10 3 cells/well), SiHa (3 × 10 3 cells/well) and C33A (5 × 10 3 cells/well) cells were inoculated into 96-well plates to detect the cell viabilities by an MTT assay. HeLa (2 × 10 2 cells/ well), SiHa (3 × 10 2 cells/well) and C33A (3 × 10 2 cells/well) cells were seeded into 12-well plates to detect the colony formation rate.
The details were described previously. 27 
| Wound healing and cell invasion assays
For the wound healing assay, the movement of cells into the scraped area was measured to determine cell migration at 0, 48 and 72 hours as described by Ref. 25 For the invasion assays, the cells at the lower surface of the filter were counted as described previously. 28 
| Statistical analyses
The significant differences between the sample means obtained from the three independent experiments were analysed using twotailed Student's t tests. Multiple group comparisons were performed by two-way analysis of variance (ANOVA). Pearson's correlation was used to assess the association between two factors. P ≤ .05 was considered statistically significant.
| RE SULTS
| INPP1 is up-regulated in cervical cancer tissues
To were used to examine the expression levels of INPP1. B, MTT assays were performed to examine the cell viability at 24, 48 or 72 h after transfection. C, Colony formation assays were used to evaluate the cell growth. HeLa and C33A cells were grown for 14 d, and the colony formation rate was calculated. D, Twenty-four hours after transfection, HeLa and C33A cells that were resuspended in 200 μL serum-free medium were seeded into inserts and were incubated for 60 h to examine the invasion abilities. After staining with crystal violet, the cells at the lower surface of the membrane were counted under a light microscope at five random fields. E, Wound healing assays were used to reveal the effect of INPP1 on the cell mobility. F, EMT-associated markers were assessed by Western blots (*: P < .05, **: P < .01, ***: P < .001) expression and promoted E-cadherin protein expression ( Figure 2F ); this finding indicates that INPP1 was able to promote EMT in HeLa and C33A cells. We also obtained similar results in SiHa cells ( Figure   S1 ). Altogether, these results indicate that INPP1 may function as an oncogene in CC cells.
| miR-27a targets and up-regulates INPP1 expression
To study the potential mechanisms underlying the dysregulation of showed that miR-27a was up-regulated in these CC tissues compared with that in the adjacent normal cervical tissues ( Figure 3A) .
The mean expression of miR-27a was increased by approximately 14-fold ( Figure 3B ). Furthermore, miR-27a also displayed a positive correlation with INPP1 ( Figure 3C) . 
| Knockdown of INPP1 abolishes the malignant phenotype induced by miR-27a in cervical cancer cells
To verify that INPP1 indeed acts as the functional target of miR- Figure S2B ), invasion ( Figure 4C , Figure S2C ) and migration ( Figure 4D , Figure S2D ). Furthermore, the abnormal expression of EMT markers caused by miR-27a was also restored to normal levels after INPP1 knockdown ( Figure 4E ). Taken together, these data suggest that INPP1 is a functional target of miR-27a.
| D ISCUSS I ON
Previous studies have reported that INPP1 is up-regulated in the vast majority of colorectal cancers. 8 A recent report found that INPP1 is a highly expressed metabolic enzyme in aggressive ovarian and melanoma cancer cells and in primary human tumours, which drives cancer aggressiveness through regulating glycolytic metabolism and glucose-derived LPA synthesis. 9 Cancer cells have a notable preference to utilize aerobic glycolysis, rather than mitochondrial oxidative phosphorylation, for glucose-dependent ATP production, which is thought to be the basis of tumour formation and growth. 29 Thus, INPP1 attracted our attention.
In this study, we demonstrated that INPP1 was more highly The dysregulation of miRNAs has been found to play key critical roles in up-or down-regulating the expression of its target gene 30 and may be a marker of progression in CC. 31 To determine the potential epigenetic mechanism of INPP1 up-regulation in CC, we investigated the regulation of miRNA on INPP1. First, bioinformatics was used to predict the miRNAs that target the 3′ UTR of INPP1, including miR-27a. A previous report suggested that the expression of miR-27a was significantly higher in cervical intraepithelial neoplasia (CIN) 2-3 compared to that in CIN1 (P = .023) and in squamous cell carcinoma (SCC) compared to that in CIN2-3 (P = .033). 32, 33 Many investigations have indicated that miR-27a is overexpressed in CC. 25, 34, 35 The potential role of miR-27a is similar to that of INPP1. Due to previous reports that miRNAs can bind to the 3′ UTR of their target transcripts and enhance their expression, 16, 17 we explored whether miR-27a exerts its role through binding to the 3′ UTR of INPP1 to increase its expression. Thus, we first applied a luciferase reporter assay to 
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